1979
DOI: 10.1136/bmj.1.6158.237-a
|View full text |Cite
|
Sign up to set email alerts
|

Effect of once-daily atenolol on ambulatory blood pressure.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
4
0

Year Published

1984
1984
2012
2012

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 63 publications
(4 citation statements)
references
References 2 publications
0
4
0
Order By: Relevance
“…5 Direct Intra-Arterial ABPM More than 30 years ago, a series of studies using direct intra-arterial ABPM to provide continuous 24hour BP was conducted by Jim Raftery and his group at Northwick Park Hospital in London and by John Floras and Peter Sleight at the John Radcliffe Hospital in Oxford in which the value of ABPM in assessing the efficacy of BP-lowering drugs was dramatically demonstrated. [6][7][8][9] In the earliest of these studies, atenolol taken once daily in the morning was shown to lower BP during the day but to have little effect on either nighttime BP or the morning rise in BP (Figure 3). The prescient conclusions of this study merit quoting in full because they are as relevant today as when they were written in 1979:…”
Section: The Origins Of Ambulatory Blood Pressure Measurementmentioning
confidence: 99%
See 1 more Smart Citation
“…5 Direct Intra-Arterial ABPM More than 30 years ago, a series of studies using direct intra-arterial ABPM to provide continuous 24hour BP was conducted by Jim Raftery and his group at Northwick Park Hospital in London and by John Floras and Peter Sleight at the John Radcliffe Hospital in Oxford in which the value of ABPM in assessing the efficacy of BP-lowering drugs was dramatically demonstrated. [6][7][8][9] In the earliest of these studies, atenolol taken once daily in the morning was shown to lower BP during the day but to have little effect on either nighttime BP or the morning rise in BP (Figure 3). The prescient conclusions of this study merit quoting in full because they are as relevant today as when they were written in 1979:…”
Section: The Origins Of Ambulatory Blood Pressure Measurementmentioning
confidence: 99%
“…If treatment aims at lowering BP to a 'normal' level (140 ⁄ 90 mm Hg) clearly it is desirable to lower it to that level throughout the 24-hour cycle. 7 The Oxford Group used intra-arterial ABPM to demonstrate the difference in efficacy and 24-hour duration of action between four b-blocking drugsatenolol, metoprolol, pindolol, and slow-release propranolol-in a double-blind randomized study ( Figure 4). Whereas all 4 b-blockers achieved a significant reduction in mean arterial BP 28 hours after the last single daily dose was taken, the extent to which each drug lowered BP differed during 24 hours and had clinic BP only been measured no difference between these 4 drugs would have emerged.…”
Section: The Origins Of Ambulatory Blood Pressure Measurementmentioning
confidence: 99%
“…Single measurements in outpatient clinics are unlikely to yield useful information on the effects of drugs on this basic cycle. If treatment aims at lowering blood pressure to a ''normal'' level (140 ⁄ 90 mmHg) clearly it is desirable to lower it to that level throughout the 24-h cycle' [75]. In another early study using intra-arterial ABPM, it was shown that whereas four beta-blockers achieved a significant reduction in mean arterial ABPM, the extent to which each drug did so differed over the 24 h, and importantly the authors highlighted a very basic principle that has too often been forgotten, namely, that had clinic BP only been measured no difference between these four drugs would have emerged [76].…”
Section: Abpm In Pharmacological Researchmentioning
confidence: 99%
“…79,80 Since then, hallmark studies have shown important corollary results with the use of 24-hour ABPM. 79,80 One such study, the HOPE (Heart Outcomes Prevention Evaluation) trial, 81 demonstrated the potential importance of 24-hour blood pressure control in regards to cardiovascular events. This study demonstrated that the angiotensin-converting enzyme inhibitor, ramipril, significantly reduced cardiovascular morbidity and mortality in patients at high risk for cardiovascular events.…”
mentioning
confidence: 99%